Annual report
2796.TEDINET S100P3F9
Period2021-06-01 → 2022-05-31
Filed2022-08-26
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 157
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥51.6bn | 2021-06-01 → 2022-05-31 | Cons. | Net sales |
| Revenue | ¥52.3bn | 2020-06-01 → 2021-05-31 | Cons. | Net sales |
| Revenue | ¥51.0bn | 2019-06-01 → 2020-05-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥51.7bn | 2018-06-01 → 2019-05-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥54.6bn | 2017-06-01 → 2018-05-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.5bn | 2021-06-01 → 2022-05-31 | Cons. | Operating income |
| Operating income | ¥1.2bn | 2020-06-01 → 2021-05-31 | Cons. | Operating income |
| Ordinary income | ¥1.5bn | 2021-06-01 → 2022-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2020-06-01 → 2021-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.0bn | 2019-06-01 → 2020-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥590m | 2018-06-01 → 2019-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2017-06-01 → 2018-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.3bn | 2021-06-01 → 2022-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.2bn | 2020-06-01 → 2021-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥447m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥426m | 2020-06-01 → 2021-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥577m | 2019-06-01 → 2020-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥23m | 2018-06-01 → 2019-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥28m | 2017-06-01 → 2018-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥458m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss |
| Net income | ¥419m | 2020-06-01 → 2021-05-31 | Cons. | Profit loss |
| Total assets | ¥23.7bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥24.7bn | at 2021-05-31 | Cons. | Assets |
| Total assets | ¥25.2bn | at 2020-05-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥24.2bn | at 2019-05-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥24.3bn | at 2018-05-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥17.0bn | at 2022-05-31 | Cons. | Liabilities |
| Total liabilities | ¥18.4bn | at 2021-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥6.7bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥6.3bn | at 2021-05-31 | Cons. | Net assets |
| Net assets / equity | ¥5.9bn | at 2020-05-31d | Cons. | Net assets |
| Net assets / equity | ¥5.6bn | at 2019-05-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥5.6bn | at 2018-05-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥4.0bn | at 2022-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.6bn | at 2021-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥4.0bn | at 2022-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.6bn | at 2021-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.5bn | at 2020-05-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.4bn | at 2019-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥3.6bn | at 2018-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥713m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.9bn | 2020-06-01 → 2021-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥895m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.3bn | 2017-06-01 → 2018-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥292m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.1bn | 2020-06-01 → 2021-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥734m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥501m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥527m | 2017-06-01 → 2018-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥1.0bn | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥728m | 2020-06-01 → 2021-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥766m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥354m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥894m | 2017-06-01 → 2018-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥47.99 | 2021-06-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.83 | 2020-06-01 → 2021-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥61.11 | 2019-06-01 → 2020-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.55 | 2018-06-01 → 2019-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.19 | 2017-06-01 → 2018-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥36.29 | 2021-06-01 → 2022-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥34.64 | 2020-06-01 → 2021-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥46.38 | 2019-06-01 → 2020-05-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥2.24 | 2018-06-01 → 2019-05-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥684.2 | at 2022-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥646.66 | at 2021-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥613.2 | at 2020-05-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥572.74 | at 2019-05-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥585.97 | at 2018-05-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 26.9% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 24.3% | at 2021-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.6% | at 2020-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.9% | at 2019-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.8% | at 2018-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.2% | 2021-06-01 → 2022-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.3% | 2020-06-01 → 2021-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.5% | 2019-06-01 → 2020-05-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 0.4% | 2018-06-01 → 2019-05-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | -0.5% | 2017-06-01 → 2018-05-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,544 | at 2022-05-31 | Cons. | Number of employees |
| Employees | 1,546 | at 2021-05-31 | Cons. | Number of employees |
| Employees | 1,555 | at 2020-05-31d | Cons. | Number of employees |
| Employees | 1,455 | at 2019-05-31d | Cons. | Number of employees |
| Employees | 1,504 | at 2018-05-31d | Cons. | Number of employees |
| Revenue | ¥1.3bn | 2021-06-01 → 2022-05-31 | Standalone | Net sales |
| Revenue | ¥1.4bn | 2020-06-01 → 2021-05-31 | Standalone | Net sales |
| Revenue | ¥1.2bn | 2019-06-01 → 2020-05-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥608m | 2018-06-01 → 2019-05-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥618m | 2017-06-01 → 2018-05-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥304m | 2021-06-01 → 2022-05-31 | Standalone | Operating income |
| Operating income | ¥352m | 2020-06-01 → 2021-05-31 | Standalone | Operating income |
| Ordinary income | ¥406m | 2021-06-01 → 2022-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥428m | 2020-06-01 → 2021-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥378m | 2019-06-01 → 2020-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥307m | 2018-06-01 → 2019-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥366m | 2017-06-01 → 2018-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥208m | 2021-06-01 → 2022-05-31 | Standalone | Income before income taxes |
| Profit before tax | ¥423m | 2020-06-01 → 2021-05-31 | Standalone | Income before income taxes |
| Net income | ¥122m | 2021-06-01 → 2022-05-31 | Standalone | Profit loss |
| Net income | ¥320m | 2020-06-01 → 2021-05-31 | Standalone | Profit loss |
| Net income | ¥264m | 2019-06-01 → 2020-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥229m | 2018-06-01 → 2019-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥241m | 2017-06-01 → 2018-05-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥14.6bn | at 2022-05-31 | Standalone | Assets |
| Total assets | ¥14.9bn | at 2021-05-31 | Standalone | Assets |
| Total assets | ¥15.6bn | at 2020-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥15.2bn | at 2019-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥14.8bn | at 2018-05-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥9.8bn | at 2022-05-31 | Standalone | Liabilities |
| Total liabilities | ¥10.1bn | at 2021-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥4.8bn | at 2022-05-31 | Standalone | Net assets |
| Net assets / equity | ¥4.8bn | at 2021-05-31 | Standalone | Net assets |
| Net assets / equity | ¥4.6bn | at 2020-05-31d | Standalone | Net assets |
| Net assets / equity | ¥4.4bn | at 2019-05-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥4.2bn | at 2018-05-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.6bn | at 2022-05-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.7bn | at 2021-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥13.11 | 2021-06-01 → 2022-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥34.39 | 2020-06-01 → 2021-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.94 | 2019-06-01 → 2020-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.1 | 2018-06-01 → 2019-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥26.67 | 2017-06-01 → 2018-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥10.03 | 2021-06-01 → 2022-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥26.03 | 2020-06-01 → 2021-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥21.29 | 2019-06-01 → 2020-05-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥24.56 | 2018-06-01 → 2019-05-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥25.79 | 2017-06-01 → 2018-05-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥14 | 2021-06-01 → 2022-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2020-06-01 → 2021-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2019-06-01 → 2020-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2018-06-01 → 2019-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥14 | 2017-06-01 → 2018-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥492.05 | at 2022-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥490.97 | at 2021-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥470.21 | at 2020-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥459.05 | at 2019-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥445.52 | at 2018-05-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 31.6% | at 2022-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.7% | at 2021-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.0% | at 2020-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.9% | at 2019-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.2% | at 2018-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 2.7% | 2021-06-01 → 2022-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2020-06-01 → 2021-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.1% | 2019-06-01 → 2020-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.6% | 2018-06-01 → 2019-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.1% | 2017-06-01 → 2018-05-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 9,673,785 | at 2022-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,615,515 | at 2021-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,560,655 | at 2020-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,239,620 | at 2019-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,039,050 | at 2018-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 60 | at 2022-05-31 | Standalone | Number of employees |
| Employees | 33 | at 2021-05-31 | Standalone | Number of employees |
| Employees | 35 | at 2020-05-31d | Standalone | Number of employees |
| Employees | 72 | at 2019-05-31d | Standalone | Number of employees |
| Employees | 76 | at 2018-05-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 93
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2021-06-01 → 2022-05-31 | ¥66m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2021-06-01 → 2022-05-31 | ¥41m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2022-05-31 | 48 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-06-01 → 2022-05-31 | ¥764m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-06-01 → 2022-05-31 | ¥764m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2022-05-31 | ¥1.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-06-01 → 2022-05-31 | ¥41m |
| Reconciling Itemsreconciling | segment assets | at 2022-05-31 | ¥55m |
| Reconciling Itemsreconciling | segment profit | 2021-06-01 → 2022-05-31 | −¥294m |
| Cosmetic Drug And Convenience Storereportable segment | capex | 2021-06-01 → 2022-05-31 | ¥89m |
| Cosmetic Drug And Convenience Storereportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥44m |
| Cosmetic Drug And Convenience Storereportable segment | employees | at 2022-05-31 | 112 pure |
| Cosmetic Drug And Convenience Storereportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥7.6bn |
| Cosmetic Drug And Convenience Storereportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥7.6bn |
| Cosmetic Drug And Convenience Storereportable segment | segment assets | at 2022-05-31 | ¥1.9bn |
| Cosmetic Drug And Convenience Storereportable segment | segment profit | 2021-06-01 → 2022-05-31 | −¥146m |
| Custody Of Medical Documentsreportable segment | capex | 2021-06-01 → 2022-05-31 | ¥16m |
| Custody Of Medical Documentsreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥41m |
| Custody Of Medical Documentsreportable segment | employees | at 2022-05-31 | 33 pure |
| Custody Of Medical Documentsreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥699m |
| Custody Of Medical Documentsreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥699m |
| Custody Of Medical Documentsreportable segment | segment assets | at 2022-05-31 | ¥2.0bn |
| Custody Of Medical Documentsreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥107m |
| Dispensing Pharmacyreportable segment | capex | 2021-06-01 → 2022-05-31 | ¥356m |
| Dispensing Pharmacyreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥415m |
| Dispensing Pharmacyreportable segment | employees | at 2022-05-31 | 1204 pure |
| Dispensing Pharmacyreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥42.0bn |
| Dispensing Pharmacyreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥42.0bn |
| Dispensing Pharmacyreportable segment | segment assets | at 2022-05-31 | ¥18.1bn |
| Dispensing Pharmacyreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥1.7bn |
| Medical Mallreportable segment | capex | 2021-06-01 → 2022-05-31 | ¥23m |
| Medical Mallreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥65m |
| Medical Mallreportable segment | employees | at 2022-05-31 | 16 pure |
| Medical Mallreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥503m |
| Medical Mallreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥503m |
| Medical Mallreportable segment | segment assets | at 2022-05-31 | ¥229m |
| Medical Mallreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥67m |
| —segment total | capex | 2021-06-01 → 2022-05-31 | ¥486m |
| —segment total | depreciation | 2021-06-01 → 2022-05-31 | ¥567m |
| —segment total | revenue | 2021-06-01 → 2022-05-31 | ¥50.8bn |
| —segment total | revenue external | 2021-06-01 → 2022-05-31 | ¥50.8bn |
| —segment total | segment assets | at 2022-05-31 | ¥22.2bn |
| —segment total | segment profit | 2021-06-01 → 2022-05-31 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-06-01 → 2022-05-31 | ¥552m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-06-01 → 2022-05-31 | ¥608m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-06-01 → 2022-05-31 | ¥51.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-06-01 → 2022-05-31 | ¥51.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-05-31 | ¥23.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-06-01 → 2022-05-31 | ¥1.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2020-06-01 → 2021-05-31 | ¥37m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2020-06-01 → 2021-05-31 | ¥46m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2020-06-01 → 2021-05-31 | ¥716m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2020-06-01 → 2021-05-31 | ¥716m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2021-05-31 | ¥1.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2020-06-01 → 2021-05-31 | ¥40m |
| Reconciling Itemsreconciling | segment assets | at 2021-05-31 | ¥56m |
| Reconciling Itemsreconciling | segment profit | 2020-06-01 → 2021-05-31 | −¥320m |
| Cosmetic Drug And Convenience Storereportable segment | capex | 2020-06-01 → 2021-05-31 | ¥39m |
| Cosmetic Drug And Convenience Storereportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥42m |
| Cosmetic Drug And Convenience Storereportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥8.0bn |
| Cosmetic Drug And Convenience Storereportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥8.0bn |
| Cosmetic Drug And Convenience Storereportable segment | segment assets | at 2021-05-31 | ¥2.0bn |
| Cosmetic Drug And Convenience Storereportable segment | segment profit | 2020-06-01 → 2021-05-31 | −¥42m |
| Custody Of Medical Documentsreportable segment | capex | 2020-06-01 → 2021-05-31 | ¥4m |
| Custody Of Medical Documentsreportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥41m |
| Custody Of Medical Documentsreportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥622m |
| Custody Of Medical Documentsreportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥622m |
| Custody Of Medical Documentsreportable segment | segment assets | at 2021-05-31 | ¥2.4bn |
| Custody Of Medical Documentsreportable segment | segment profit | 2020-06-01 → 2021-05-31 | ¥64m |
| Dispensing Pharmacyreportable segment | capex | 2020-06-01 → 2021-05-31 | ¥698m |
| Dispensing Pharmacyreportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥410m |
| Dispensing Pharmacyreportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥42.5bn |
| Dispensing Pharmacyreportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥42.5bn |
| Dispensing Pharmacyreportable segment | segment assets | at 2021-05-31 | ¥18.5bn |
| Dispensing Pharmacyreportable segment | segment profit | 2020-06-01 → 2021-05-31 | ¥1.4bn |
| Medical Mallreportable segment | capex | 2020-06-01 → 2021-05-31 | ¥1m |
| Medical Mallreportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥64m |
| Medical Mallreportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥491m |
| Medical Mallreportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥491m |
| Medical Mallreportable segment | segment assets | at 2021-05-31 | ¥278m |
| Medical Mallreportable segment | segment profit | 2020-06-01 → 2021-05-31 | ¥60m |
| —segment total | capex | 2020-06-01 → 2021-05-31 | ¥743m |
| —segment total | depreciation | 2020-06-01 → 2021-05-31 | ¥559m |
| —segment total | revenue | 2020-06-01 → 2021-05-31 | ¥51.6bn |
| —segment total | revenue external | 2020-06-01 → 2021-05-31 | ¥51.6bn |
| —segment total | segment assets | at 2021-05-31 | ¥23.1bn |
| —segment total | segment profit | 2020-06-01 → 2021-05-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-06-01 → 2021-05-31 | ¥780m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-06-01 → 2021-05-31 | ¥606m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-06-01 → 2021-05-31 | ¥52.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-06-01 → 2021-05-31 | ¥52.3bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-05-31 | ¥24.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-06-01 → 2021-05-31 | ¥1.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,583
| Item | Context | Value | Unit |
|---|---|---|---|
| Net assets (5-year summary) | Prior1YearInstant | 6331000000 | JPY |
| Net assets (5-year summary) | CurrentYearInstant | 6699000000 | JPY |
| Total assets (5-year summary) | Prior4YearInstant | 24265000000 | JPY |
| Total assets (5-year summary) | Prior3YearInstant | 24217000000 | JPY |
| Total assets (5-year summary) | Prior2YearInstant | 25206000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 24724000000 | JPY |
| Total assets (5-year summary) | CurrentYearInstant | 23746000000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant | 585.97 | |
| Net assets per share (5-year summary) | Prior3YearInstant | 572.74 | |
| Net assets per share (5-year summary) | Prior2YearInstant | 613.20 | |
| Net assets per share (5-year summary) | Prior1YearInstant | 646.66 | |
| Net assets per share (5-year summary) | CurrentYearInstant | 684.20 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | -3.19 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | 2.55 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | 61.11 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 45.83 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | 47.99 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | 2.24 | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | 46.38 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 34.64 | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | 36.29 | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant | 0.218 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | 0.219 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant | 0.226 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.243 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant | 0.269 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration | -0.005 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration | 0.004 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration | 0.105 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration | 0.073 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration | 0.072 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior3YearDuration | 201.2 | |
| Price earnings ratio (5-year summary) | Prior2YearDuration | 10.8 | |
| Price earnings ratio (5-year summary) | Prior1YearDuration | 16.9 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration | 15.2 | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration | 1330000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration | 895000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration | 1572000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1945000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration | 713000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration | -527000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration | -501000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration | -734000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -1076000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | -292000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration | -894000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | 354000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | -766000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |